Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsBy modifying a functional polypeptide on the mesenchymal stem cell plasma membrane and exploiting the high expression of transglutaminase 2 in the regions of injured cartilage, researchers achieved targeted recognition and capture of modified MSCs by injured articular chondrocytes
[Biomaterials]
6445212 JBXLGHN8 items 1 apa 0 default asc 1 164192 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-95ef7898b0be9caeb16bc0550f816d46%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22JBXLGHN8%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Li%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELi%2C%20H.%2C%20Jin%2C%20Y.%2C%20Zhao%2C%20Y.%2C%20Li%2C%20W.%2C%20He%2C%20Z.%2C%20Zhang%2C%20Q.%2C%20Huang%2C%20H.%2C%20Lin%2C%20J.%2C%20Chen%2C%20Y.%2C%20Xing%2C%20D.%2C%20Du%2C%20Y.%2C%20%26amp%3B%20Lin%2C%20J.%20%282021%29.%20Targeted%20cell%20therapy%20for%20partial-thickness%20cartilage%20defects%20using%20membrane%20modified%20mesenchymal%20stem%20cells%20by%20transglutaminase%202.%20%3Ci%3EBiomaterials%3C%5C%2Fi%3E%2C%20%3Ci%3E275%3C%5C%2Fi%3E%2C%20120994.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.biomaterials.2021.120994%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.biomaterials.2021.120994%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DJBXLGHN8%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeted%20cell%20therapy%20for%20partial-thickness%20cartilage%20defects%20using%20membrane%20modified%20mesenchymal%20stem%20cells%20by%20transglutaminase%202%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hui%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuhong%22%2C%22lastName%22%3A%22Jin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenjing%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zihao%22%2C%22lastName%22%3A%22He%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qingxi%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hesuyuan%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jianjing%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuyang%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dan%22%2C%22lastName%22%3A%22Xing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanan%22%2C%22lastName%22%3A%22Du%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jianhao%22%2C%22lastName%22%3A%22Lin%22%7D%5D%2C%22abstractNote%22%3A%22Unlike%20full-thickness%20cartilage%20defects%20%28FCD%29%2C%20partial-thickness%20cartilage%20defects%20%28PCD%29%20may%20still%20have%20residual%20healthy%20cartilage%20tissue%2C%20and%20therefore%2C%20the%20conventional%20clinical%20treatments%20such%20as%20microfracture%20and%20autologous%20chondrocyte%20implantation%20%28ACI%29%20are%20so%20traumatic%20that%20they%20may%20not%20be%20the%20suitable%20therapies%20for%20PCD.%20Although%20intra-articular%20injection%20of%20mesenchymal%20stem%20cells%20%28MSCs%29%20is%20a%20minimally%20invasive%20treatment%2C%20its%20therapeutic%20efficacy%20is%20markedly%20limited%20due%20to%20anoikis%20caused%20by%20failure%20of%20cell%20colonization%20in%20the%20injured%20area.%20By%20modifying%20a%20functional%20polypeptide%20on%20the%20MSC%20plasma%20membrane%20and%20exploiting%20the%20high%20expression%20of%20transglutaminase%202%20%28TGase2%29%20in%20the%20regions%20of%20injured%20cartilage%2C%20we%20achieved%20targeted%20recognition%20and%20capture%20of%20modified%20MSCs%20by%20injured%20articular%20chondrocytes%20%28ACs%29.%20In%20the%20in%20vitro%20co-culture%20model%2C%20MSCs%20improved%20the%20function%20of%20injured%20ACs%20and%20enhanced%20the%20chondrogenic%20differentiation%20potential%20of%20MSCs.%20Results%20of%20in%20vitro%20study%20also%20revealed%20that%20the%20activation%20of%20the%20AKT%5C%2FmTOR%20signaling%20pathway%20may%20play%20an%20important%20role%20in%20the%20treatment%20of%20injured%20ACs%20by%20MSCs.%20Further%2C%20membrane-modified%20MSCs%20exhibited%20a%20better%20therapeutic%20effect%20than%20wide-type%20MSCs%20in%20a%20rabbit%20model%20of%20PCD.%20Thus%2C%20this%20unique%20cell%20membrane%20modification%20strategy%20provides%20a%20new%20cell-based%20therapeutic%20approach%20for%20the%20early%20treatment%20of%20articular%20cartilage%20defects%20and%20other%20joint%20diseases.%22%2C%22date%22%3A%22August%201%2C%202021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.biomaterials.2021.120994%22%2C%22ISSN%22%3A%220142-9612%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0142961221003501%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-07-05T17%3A38%3A43Z%22%7D%7D%5D%7D
Li, H., Jin, Y., Zhao, Y., Li, W., He, Z., Zhang, Q., Huang, H., Lin, J., Chen, Y., Xing, D., Du, Y., & Lin, J. (2021). Targeted cell therapy for partial-thickness cartilage defects using membrane modified mesenchymal stem cells by transglutaminase 2. Biomaterials, 275, 120994. https://doi.org/10.1016/j.biomaterials.2021.120994 Cite
